« Exercising caution over unproven therapies: India holds public consultation meetings to update stem cell guidelines | Main | The “Viagra effect”: how known drugs can be repurposed to target cancer stem cells »

January 17, 2012

Trading on hope: A look at what motivates stem cell tourists and what happens when it goes wrong

Rudnicki16x9

In recent years, the research community has been quite outspoken in its condemnation of rogue stem cell clinics operating in many countries across the globe. Indeed, through announcements made by health and related ministries in China, India and the US, it appears the message is beginning to be heard.  

On the heels of a recent 60 Minutes newscast in the US, a similar exposé aired on January 14 here in Canada. In it, Stem Cell Network Scientific Director Michael Rudnicki spoke with Global TV’s Carolyn Jarvis, condemning stem cell tourism and the agencies that offer them as “despicable” (view the entire Global TV 16x9 segment here). His interview was just a small part of the broadcast, in which the news team looked at the unproven and unapproved therapies offered by a clinic operating in Mexico and a Canadian-based travel operator that offers packages to help people access the services.

Along with Rudnicki, the program profiles several patients, one of whom was successfully treated in an FDA-approved clinical trial for MS, another who was unsuccessfully treated in a Mexican clinic, and a set of parents raising funds to seek treatment in China for their five-year-old son. Each of the struggle to balance the pain of dealing with their ailments, the hope that stem cells could help them, and the risks involved in these experimental therapies.

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a010536e77446970c016760b08123970b

Listed below are links to weblogs that reference Trading on hope: A look at what motivates stem cell tourists and what happens when it goes wrong:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.